Becky Burdine impacts the rare disease community, the Angelman syndrome community and the scientific community in every way possible. Her approach is science driven and starts with the families in her community.

Dr. Burdine is parent to a child with Angelman Syndrome, and was a founding member and Chief Scientific Officer for the Foundation for Angelman Syndrome Therapeutics from 2008 until 2016. She also served on the Scientific Advisory Board for the Angelman Syndrome Foundation. Dr. Burdine is Associate Professor of Molecular Biology at Princeton University and currently serves as Chief Scientific Officer for the Pitt-Hopkins Research Foundation.

Also, in this episode we introduce BOLD MOVE, a new part of the program where Amit answers questions from the rare disease community.